4.4 Review

Anti-cocaine vaccine development

Journal

EXPERT REVIEW OF VACCINES
Volume 9, Issue 9, Pages 1109-1114

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1586/ERV.10.102

Keywords

cocaine; immunotherapy; substance abuse; vaccination

Categories

Funding

  1. Department of Veterans Affairs
  2. Mental Illness Research, Education and Clinical Center [VISN 16]
  3. Veterans' Affairs National Substance Use Disorders Quality Enhancement Research Initiative
  4. National Institute on Drug Abuse [5R01 DA 26859, K05 DA 0454, P50-DA18197]
  5. NATIONAL INSTITUTE ON DRUG ABUSE [P50DA018197, K05DA000454, U01DA023898, R01DA025223, R01DA026859] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Cocaine abuse is an ongoing and serious problem that has led to the growth of a brutal criminal enterprise, particularly in the Americas and Europe. At present, there are no effective pharmacological agents available to treat the addiction by blocking cocaine or reversing its effects. In order to help motivated addicts conquer their addiction, vaccines against cocaine are being developed and one has progressed to clinical trials. This article will discuss the concept of antidrug vaccines in general, the successes and limitations of the various anti-cocaine vaccine approaches, the results of the clinical trials with an anti-cocaine vaccine and some new vaccine-mediated approaches to combat cocaine addiction.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available